Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries. To further enhance the protective immune responses in populations that have completed vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jialu, He, Qian, An, Chaoqiang, Mao, Qunying, Gao, Fan, Bian, Lianlian, Wu, Xing, Wang, Qian, Liu, Pei, Song, Lifang, Huo, Yaqian, Liu, Siyuan, Yan, Xujia, Yang, Jinghuan, Cui, Bopei, Li, Changgui, Wang, Junzhi, Liang, Zhenglun, Xu, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381941/
https://www.ncbi.nlm.nih.gov/pubmed/34278956
http://dx.doi.org/10.1080/22221751.2021.1957401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381941/
https://www.ncbi.nlm.nih.gov/pubmed/34278956
http://dx.doi.org/10.1080/22221751.2021.1957401

Ejemplares similares